Kolon TissueGene, Inc. — Form D

Kolon TissueGene, Inc. of ROCKVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-29. The offering totals $29.6M, of which $29.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Jangik Su LeeDirectorRockville, MD
Soon-Wook Joon KweonExecutive OfficerRockville, MD
Yonggyun Joon JeongExecutive OfficerRockville, MD
Gun Young Joon ParkExecutive OfficerRockville, MD
Sun Jin Joon KimExecutive OfficerRockville, MD
Jung In KimDirectorRockville, MD
Jung In KimExecutive OfficerRockville, MD
Sun Joo LeeDirectorRockville, MD
Charles Joon NyeExecutive OfficerRockville, MD
Young Joon KimExecutive OfficerRockville, MD
Diana HalimExecutive OfficerRockville, MD
Moon Jong NohDirectorRockville, MD
Moon Jong NohExecutive OfficerRockville, MD
Charles Stephen NyeExecutive OfficerRockville, MD
Sung Su HanDirectorRockville, MD
Sung Su HanExecutive OfficerRockville, MD
Gun Young Stephen ParkExecutive OfficerRockville, MD
Moon Jong Su NohDirectorRockville, MD
Moon Jong Su NohExecutive OfficerRockville, MD
Jung In Su KimDirectorRockville, MD
Jung In Su KimExecutive OfficerRockville, MD
Diana Stephen HalimExecutive OfficerRockville, MD
Sun Joo Su LeeDirectorRockville, MD
Min Seok Su KimDirectorRockville, MD
Min Seok Su KimExecutive OfficerRockville, MD

Other filings by this issuer (3)

FiledFormOfferingSold
2024-06-05D$35.0M$35.0M
2023-05-15D$30.0M$30.0M
2021-12-16D$30.1M$30.1M

More